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Abstract
Introduction: We present a case of long-term evolution of a submandibular pleomorphic adenoma. There is little
information about topographic malignant transformation patterns of pleomorphic adenomas.
Case presentation: We extensively analyze a giant submandibular mixed tumor of 25-year evolution in a 57-year-
old Caucasian woman. Deoxyribonucleic acid ploidy was evaluated in different superficial and deep areas using
flow cytometry analysis and correlated with pathological and immunohistochemical characteristics. Superficial areas
exhibited a typical histological pleomorphic adenoma pattern and were deoxyribonucleic acid diploid. Deep
samples showed deoxyribonucleic acid aneuploidy, atypical histological benign features and expression of markers
involved at an early-stage of malignant transformation, such as tumor protein 53 and antigen Ki67.
Conclusion: These findings revealed that deep tumor compartments may be involved in the initial stages of
malignant transformation. Deoxyribonucleic acid ploidy analysis may provide an additional diagnosis tool and
indicate ‘uncertain’ areas that require careful study to avoid diagnostic errors. Larger studies are needed to confirm
our results and to evaluate the usefulness of the technique.
Introduction
Pleomorphic adenomas (PAs) are the most common
benign tumors arising in salivary glands and their malig-
nant transformation to carcinoma ex pleomorphic ade-
nomas (CXPAs) accounts for between 4.5% and 15% of
all cancers of these glands [1]. The diagnosis of CXPA
is based on the coexistence of epithelial malignancy with
histologically benign PA [2]. These tumors are typically
considered as high-grade carcinomas, with frequent
metastases and disease-related deaths [3].
Long-term evolution of a PA might increase the risk
of malignant transformation [4]. Although rare, cases of
giant PA have been reported, most of them involving
the parotid gland [5-7]. Misdiagnosis is not rare in these
cases, because the CXPA component may be small and
therefore missed on histological analysis. There are few
series published in the literature focusing on ploidy ana-
lysis for the prediction of tumor aggressiveness and for
differentiating benign from malignant salivary gland
tumors [8-10]. However, a lack of correlation between
cytometric parameters and histological or immunohisto-
chemical parameters has not been described.
The objective of this case report was to analyze a giant
PA tumor of 25-year evolution. Deoxyribonucleic acid
(DNA) ploidy was evaluated in different areas using flow
cytometry analysis, and correlated with pathological and
immunohistochemical characteristics in order to assess
whether ploidy analysis may improve the diagnostic
accuracy for predicting malignancy.
Case presentation
A 57-year-old Caucasian woman presented with a large
non-tender submandibular mass. The lesion had been
present for about 25 years with a slow increase in size.
Our patient’s medical history was unremarkable. A phy-
sical examination revealed a giant painless, movable,
semi-hard elastic mass in her right submandibular
region measuring about 8×6 cm. Fine needle aspiration
cytology was suggestive of a PA. Contrast-enhancement
computerized tomography confirmed a giant well-
defined mass without cystic changes in her right
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submandibular region (Figure 1). No lymph node swel-
ling or other tumorous lesions were detected. Subman-
dibular tumor extirpation was performed under general
anesthesia.
Immediately after removal, samples were obtained in
the surgery room following a topographic scheme (Fig-
ure 2). Group 1 comprised six samples from the periph-
ery of the tumor, adjacent to the subcutaneous tissue;
group 2 comprised six samples from the periphery of
the tumor, adjacent to the floor of the mouth; and for
group 3, the tumor was opened along the midline, and
six deep samples were extracted from the center of the
tumor.
Half of the samples in each group were fixed in 4%
buffered formalin, processed and embedded in paraffin
according to routine procedures, for histological and
immunohistochemical analysis. The remainder of the
samples of fresh material for each group were
immediately submitted for DNA flow cytometry. The
rest of the surgical specimen was routinely studied in
the Department of Pathology and diagnosed as a benign
PA.
Samples of each group were minced with a scalpel in
phosphate-buffered saline solution. Single nuclear sus-
pensions were prepared by filtering through a 50-μm
nylon mesh. The DNA contents were measured in a
Cytomics FC500 (Beckman Coulter Inc., Fullerton, CA,
USA) flow cytometer. DNA histograms of at least 10,
000 nuclei were plotted. The DNA-diploid cell popula-
tion corresponding to surrounding normal tissue from
the same location was used as an internal reference
standard for the identification of DNA-aneuploid clones.
The percentages of the cell cycle phases as well as the
DNA indices of the aneuploid clones were calculated
using the Modfit 5.2 software package. DNA histograms
were classified as diploid if there was a single G0-G1
peak and aneuploid if additional G0-G1 peaks were pre-
sent. The ratio of aneuploid G0-G1 peak values to
diploid G0-G1 peak values was expressed as a DNA
index. All specimens had a G0-G1 peak coefficient of
variation of no more than 4%. The following were taken
as cytometric variables: DNA ploidy, DNA index, and S-
phase fraction. The cases with DNA indices between 0.9
and 1.10 were considered as DNA diploids, and those
less than 0.9 or greater than 1.10 as DNA aneuploids.
Half of the paraffin-embedded samples of all three
groups were routinely stained with hematoxylin and
eosin. The rest of the paraffin samples were submitted
to the labeled-polymer method of immunohistochemis-
try using antibodies against a-smooth-muscle actin (a-
SMA), cytokeratin (CK) AE1/AE3, CK 8, protein 53
(p53), protein 63 (p63) and antigen Ki67.
The histogram of Group 1 samples presented a single
peak in the G0-G1 area. The cell nuclei population was
5.91% in the G2 region and 91.30% in the G1 area. The
proportion of cells in the S-phase was 2.78% and the coef-
ficient of variance (CV) was 3.70%. Samples of this group
were considered as being DNA diploid (Figure 3A). Group
2 samples also exhibited a DNA diploid pattern with an
88.26% nuclei population in the G1 region and 8.80% in
the G2 area. The S-phase fraction was 2.95% and the CV
was 3.04% (Figure 3B). Group 3 samples showed DNA
aneuploidy: 48.70% of the cell population was considered
diploid with 4.18% in the G2 region, 91.27% in the G1
area and a CV of 2.17%, whereas 51.30% of the cells ana-
lyzed presented an aneuploid pattern with 10.53% in the
G2 region, 89.03% in the G1 area and a CV of 7.08%. The
total aneuploid S-phase was 0.44% and the total S-phase
fraction was 2.45% (Figure 3C).
Histological analysis of Group 1 and Group 2 samples
showed ductal structures, cords and islands of polygonal
cells without atypia, sheets and strands of hyaline or
Figure 1 Preoperative computed tomography scan
demonstrating a large well-defined mass without cystic
changes or necrotic areas in the right submandibular region.
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plasmacytoid cells in a myxoid stroma. These findings
were consistent with PA (Figure 4A). On immunohisto-
chemistry, slight positivity was observed in the ductal
cells with CK AE1/AE3 and CK 8 (Figure 4C-F). The
non-luminal cells strongly expressed a-SMA (Figure
4B). Occasional cells were positive with proliferation
antigen Ki67 and no expression was observed with p53
(Figure 4D-G). Otherwise, myoepithelial cells showed
high positive nuclear staining for p63 (Figure 4E).
Group 3 samples exhibited an unusual histological
pattern. These hypercellular areas were composed of
blocks of round to ovoid epithelial cells without the
‘reminiscent’ myoepithelium. The epithelial cells were
round with pale eosinophilic cytoplasm and round to
oval nuclei. Nuclear pleomorphism or atypia, malignant
luminal cells and necrotic foci were not observed (Fig-
ure 5A). The immunohistochemical study showed
strong expression of CKs AE1/AE3 and CK 8 in most of
the epithelial cells (Figure 5C-F). p63 and a-SMA stain-
ing were seen to a lesser degree than in the Group 1
and 2 samples (Figure 5B-E) whereas expression of anti-
gen Ki67 was more intense (Figure 5G). p53 was
expressed in a few epithelial cells (Figure 5D).
Discussion
PA is the most common benign salivary gland tumor
[1,2]. It is derived from the epithelium and typically pre-
sents as a cytologically benign circumscribed mass with
variable encapsulation. This tumor is one of the few
benign neoplasms than can undergo malignant transfor-
mation. The propensity for malignant transformation
has been documented in the literature at 1.9% to 23.3%
and CXPA represents approximately 12% of malignant
neoplasms [2,11,12]. Otherwise, it has been estimated
that approximately 25% of untreated mixed tumors
would eventually develop into carcinomas [13]. The
likelihood of a malignant change in a PA increases with
the duration of the tumor and with the age of the
patient. The diagnosis of CXPA requires the presence of
either a recognizable mixed tumor in association with a
carcinoma or carcinoma developing as a recurrent neo-
plasm at the site of a previous mixed tumor. Criteria for
malignancy include invasiveness, cellular anaplasia or
pleomorphism, atypical mitosis and abnormal architec-
tural patterns [1,3].
It is currently postulated that malignant transforma-
tion is accompanied by genomic instability (cytogenetic
and/or cytometric aneuploidy) [14]. DNA ploidy analysis
has proven to be a useful prognostic indicator in a vari-
ety of salivary gland neoplasms. Abnormal DNA content
has been related to aggressive behavior in adenoid cystic
carcinomas, acinic cell carcinomas, mucoepidermoid
carcinomas and oncocytomas [8,9]. Otherwise, most
likely due to the low incidence of malignant salivary
gland tumors, only a few attempts have been made to
employ DNA ploidy analysis for diagnostic assessment
[10,15]. One purpose of the present study was to deter-
mine whether DNA ploidy analysis is a good diagnostic
tool to distinguish malignant areas in PAs even before
histopathological correlation.
Some authors reported that DNA diploidy may be
seen in both benign and malignant lesions, but aneu-
ploidy is mainly seen in malignant lesions. In the major-
ity of previous studies, the PAs revealed a diploid
pattern [8,9,15]. However, Martin et al. examined a ser-
ies of 16 mixed tumors and found DNA aneuploidy in
four cases, three of which were recurrent lesions [16]. In
our tumor, deep samples (Group 3) demonstrated aneu-
ploidy correlated with atypical histological and immuno-
histochemical features. This central area exhibited a
hypercellular pattern, with a predominantly epithelial
pattern and a lack or poor myoepithelial cells and
Figure 2 Macroscopic overview of the resected pleomorphic adenoma and topographic mapping of the samples obtained. Group 1:
superficial samples adjacent to subcutaneous tissue; group 2: superficial samples adjacent to the floor of the mouth; group 3: deep samples.
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stroma. Immunohistochemistry for CKs AE1/AE3 and
CK 8 confirmed the glandular (luminal) differentiation
of the epithelial portion of this tumor. Otherwise, p63
antibody and a-SMA have been shown to be reliable
myoepithelial and basal cell markers, and presented
minor staining in the deep area. PA typical areas, the
Group 1 and 2 samples, characteristically show a vari-
able amount of myxochondroid stroma produced by
myoepithelial cells. Chau and Radden studied 53 cases
of intraoral PA, and reported that stroma-poor PAs
were larger than stroma-rich ones, and suggested that
cellular tumors may grow at a faster rate [17]. Other
studies described that, although the myoepithelial com-
ponent predominates in most PAs, the genetic changes
leading to malignant transformation occur more fre-
quently in ductal luminal cells than in myoepithelial
cells [18,19].
In addition, p53 and Ki67 presented higher expression
in deep compared to superficial areas. It has been sug-
gested that the index of p53 and Ki67 accumulation
could be a useful biomarker for detecting tumors at an
early phase of malignant transformation and distinguish
PA from CXPA areas [18]. Therefore, Group 3 samples
presented a hypercellular benign pattern, without dys-
plasia or obvious malignant change, but also showed
DNA aneuploidy and expressed markers involved at an
early stage of malignant transformation. It is tempting
to postulate a future progression to CXPA in this area.
Figure 3 Histograms from flow cytometry on the fresh material. (A) Histogram of group 1 samples showing a single peak in the G0-G1
area (DNA diploid). (B) Histogram of group 2 samples also exhibiting a diploid pattern. (C) Histogram of group 3 (deep) samples demonstrating
DNA aneuploidy.
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Conclusion
There is little information in the literature regarding
topographic malignant transformation patterns of PA.
This study revealed that deep tumor compartments
may be involved in the initial stages of malignant
transformation. The authors of the present study sug-
gest that deep areas in long-term evolution PAs
should be carefully assessed by serial sectioning to
document evidence of malignancy. In conclusion,
DNA ploidy analysis may provide an additional
Figure 4 Histological and immunohistochemical evaluation of superficial areas (groups 1 and 2). (A) Hematoxylin and eosin staining
showing cords and islands of polygonal cells without atypia in a myxoid stroma (200× magnification). (B) Basal and myoepithelial cells highly
exhibited a-SMA (200× magnification). (C) Slight positivity with CK 8 was observed (200× magnification). (D) No expression was observed with
p53 (200× magnification). (E) Basal and myoepithelial cells highly exhibited p63 (200× magnification). (F) Slight positivity with CKs AE1/AE3 was
observed (200× magnification). (G) Only occasional cells were positive with antigen Ki67 (100× magnification).
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diagnosis tool for ‘uncertain’ areas. The prognosis and
future therapy will depend on careful study of these
lesions. Obviously, more cases are needed to evaluate
these results and better understand this entity.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any
accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this
journal.
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Figure 5 Histological and immunohistochemical evaluation of the deep area (group 3). (A) Hematoxylin and eosin staining showing
hypercellular areas composed of round to ovoid epithelial cells, without nuclear pleomorphism or atypia (200× magnification). (B)
Immunostaining with a-SMA was only detected in a few myoepithelial cells (100× magnification). (C) CK 8 was strongly expressed in most of
the tumoral cells (200× magnification). (D) Positivity to p53 was detected in a few epithelial cells (200× magnification). (E) Immunostaining with
p63 was only detected in a few myoepithelial cells (100× magnification). (F) CKs AE1/AE3 were strongly expressed in most of the tumoral cells
(100× magnification). (G) Stronger expression of Ki67 antigen than in groups 1 and 2 was observed (100× magnification).
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